1,709 Cigna Group $CI Shares Sold by Drive Wealth Management LLC

Drive Wealth Management LLC trimmed its position in Cigna Group (NYSE:CI – Free Report) by 57.5% during the third quarter, HoldingsChannel.com reports. The firm owned 1,265 shares of the health services provider’s stock after selling 1,709 shares during the quarter. Drive Wealth Management LLC’s holdings in Cigna Group were worth $344,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. McKinney Capital Management LLC bought a new position in shares of Cigna Group during the third quarter worth about $1,373,000. Diversified Trust Co raised its position in Cigna Group by 42.1% in the 3rd quarter. Diversified Trust Co now owns 4,429 shares of the health services provider’s stock valued at $1,204,000 after buying an additional 1,313 shares during the last quarter. Vista Capital Partners Inc. acquired a new stake in Cigna Group in the 3rd quarter valued at approximately $332,000. Aberdeen Group plc raised its position in Cigna Group by 389.6% in the 3rd quarter. Aberdeen Group plc now owns 1,078,857 shares of the health services provider’s stock valued at $283,907,000 after buying an additional 858,488 shares during the last quarter. Finally, Allworth Financial LP lifted its stake in Cigna Group by 7.5% in the 3rd quarter. Allworth Financial LP now owns 34,925 shares of the health services provider’s stock valued at $9,628,000 after acquiring an additional 2,444 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Price Performance

Shares of NYSE CI opened at $296.79 on Monday. The stock has a market capitalization of $78.20 billion, a price-to-earnings ratio of 13.10, a PEG ratio of 1.11 and a beta of 0.25. The business has a 50-day moving average of $287.53 and a 200-day moving average of $282.70. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a fifty-two week low of $257.85 and a fifty-two week high of $318.05.

Cigna Group (NYSE:CI – Get Free Report) last released its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The business had revenue of $73.79 billion for the quarter, compared to the consensus estimate of $72.64 billion. During the same quarter in the previous year, the business earned $7.83 earnings per share. Cigna Group’s quarterly revenue was up 5.6% on a year-over-year basis. As a group, sell-side analysts predict that Cigna Group will post 30.71 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s dividend payout ratio (DPR) is currently 27.54%.

Recent Cigna Group Headlines

These are some of the CI headlines that stood out recently:

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. The trade was a 9.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CI shares. Piper Sandler reduced their price target on Cigna Group from $370.00 to $360.00 and set an “overweight” rating for the company in a research report on Thursday. Barclays lifted their price objective on shares of Cigna Group from $310.00 to $320.00 and gave the company an “equal weight” rating in a report on Monday, November 9th. Sanford C. Bernstein lifted their price objective on shares of Cigna Group from $387.00 to $390.00 and gave the company an “outperform” rating in a report on Wednesday. Cantor Fitzgerald reissued an “overweight” rating and issued a $340.00 price objective on shares of Cigna Group in a research report on Friday, November 6th. Finally, Jefferies Financial Group increased their target price on shares of Cigna Group from $288.00 to $304.00 and gave the stock a “hold” rating in a report on Thursday. Fourteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $336.90.

Check Out Our Latest Stock Analysis on CI

Cigna Group Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.